市場調査レポート
商品コード
1491570

放射性医薬品の世界市場 2024-2028

Global radiopharmaceuticals market 2024-2028

出版日: | 発行: TechNavio | ページ情報: 英文 166 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.74円
放射性医薬品の世界市場 2024-2028
出版日: 2024年05月17日
発行: TechNavio
ページ情報: 英文 166 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

放射性医薬品市場は2023-2028年に62億8,060万米ドル、予測期間中のCAGRは12.17%で成長すると予測されます。

当レポートでは、放射性医薬品市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、神経疾患の罹患率の上昇、がん症例の増加、腫瘍学市場への投資の増加、放射性医薬品の副作用の最小化などが牽引しています。

市場範囲
基準年 2024
終了年 2028
予測期間 2024-2028
成長モメンタム 加速
前年比2024年 10.62%
CAGR 12.17%
増分額 62億8,060万米ドル

本調査では、サイクロトロンベースの放射性医薬品の生産が、今後数年間の放射性医薬品市場成長を牽引する主要因の一つであると特定しています。また、新しい放射性医薬品の発見と開発、新興経済諸国におけるヘルスケアインフラの改善が、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 市場情勢

  • 市場エコシステム
  • 市場の特徴
  • バリューチェーン分析

第3章 市場規模の評価

  • 市場の定義
  • 市場セグメント分析
  • 市場規模 2023
  • 市場の見通し 2023-2028

第4章 市場規模実績

  • 世界放射性医薬品市場 2018-2022
  • ソースセグメント分析 2018-2022
  • エンドユーザーセグメント分析 2018-2022
  • 地域別セグメント分析 2018-2022
  • 国別セグメント分析 2018-2022

第5章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

第6章 市場セグメンテーション:ソース別

  • 市場セグメンテーション
  • 比較:ソース別
  • サイクロトロン:市場規模と予測 2023-2028
  • 原子炉:市場規模と予測 2023-2028
  • 市場機会:ソース別

第7章 市場セグメンテーション:エンドユーザー別

  • 市場セグメンテーション
  • 比較:エンドユーザー別
  • 診断:市場規模と予測 2023-2028
  • 治療薬:市場規模と予測 2023-2028
  • 市場機会:エンドユーザー別

第8章 顧客情勢

  • 顧客情勢の概要

第9章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米:市場規模と予測 2023-2028
  • 欧州:市場規模と予測 2023-2028
  • アジア:市場規模と予測 2023-2028
  • 世界のその他の地域:市場規模と予測 2023-2028
  • 米国:市場規模と予測 2023-2028
  • ドイツ:市場規模と予測 2023-2028
  • 英国:市場規模と予測 2023-2028
  • カナダ:市場規模と予測 2023-2028
  • 中国:市場規模と予測 2023-2028
  • 市場機会:地域情勢別

第10章 促進要因・課題・機会・抑制要因

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場の機会・抑制要因

第11章 競合情勢

  • 概要
  • 競合情勢
  • 混乱の状況
  • 業界のリスク

第12章 競合分析

  • 企業プロファイル
  • 企業の市場ポジショニング
  • Bayer AG
  • Bracco Spa
  • Cardinal Health Inc.
  • Curium Pharma
  • Eckert and Ziegler AG
  • General Electric Co.
  • IBA Radiopharma Solutions
  • Jubilant Pharmova Ltd.
  • Lantheus Holdings Inc.
  • NorthStar Medical Radioisotopes LLC
  • Novartis AG
  • NTP Radioisotopes SOC Ltd.
  • PharmaLogic Holdings Corp.
  • Siemens AG
  • Sotera Health Co.

第13章 付録

図表

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Source
  • Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Company Market Positioning
  • Exhibits10: Parent Market
  • Exhibits11: Data Table on - Parent Market
  • Exhibits12: Market characteristics analysis
  • Exhibits13: Value Chain Analysis
  • Exhibits14: Offerings of companies included in the market definition
  • Exhibits15: Market segments
  • Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits20: Historic Market Size - Data Table on Global Radiopharmaceuticals Market 2018 - 2022 ($ million)
  • Exhibits21: Historic Market Size - Source Segment 2018 - 2022 ($ million)
  • Exhibits22: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
  • Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
  • Exhibits25: Five forces analysis - Comparison between 2023 and 2028
  • Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
  • Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
  • Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
  • Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
  • Exhibits31: Chart on Market condition - Five forces 2023 and 2028
  • Exhibits32: Chart on Source - Market share 2023-2028 (%)
  • Exhibits33: Data Table on Source - Market share 2023-2028 (%)
  • Exhibits34: Chart on Comparison by Source
  • Exhibits35: Data Table on Comparison by Source
  • Exhibits36: Chart on Cyclotrons - Market size and forecast 2023-2028 ($ million)
  • Exhibits37: Data Table on Cyclotrons - Market size and forecast 2023-2028 ($ million)
  • Exhibits38: Chart on Cyclotrons - Year-over-year growth 2023-2028 (%)
  • Exhibits39: Data Table on Cyclotrons - Year-over-year growth 2023-2028 (%)
  • Exhibits40: Chart on Nuclear reactors - Market size and forecast 2023-2028 ($ million)
  • Exhibits41: Data Table on Nuclear reactors - Market size and forecast 2023-2028 ($ million)
  • Exhibits42: Chart on Nuclear reactors - Year-over-year growth 2023-2028 (%)
  • Exhibits43: Data Table on Nuclear reactors - Year-over-year growth 2023-2028 (%)
  • Exhibits44: Market opportunity by Source ($ million)
  • Exhibits45: Data Table on Market opportunity by Source ($ million)
  • Exhibits46: Chart on End-user - Market share 2023-2028 (%)
  • Exhibits47: Data Table on End-user - Market share 2023-2028 (%)
  • Exhibits48: Chart on Comparison by End-user
  • Exhibits49: Data Table on Comparison by End-user
  • Exhibits50: Chart on Diagnostics - Market size and forecast 2023-2028 ($ million)
  • Exhibits51: Data Table on Diagnostics - Market size and forecast 2023-2028 ($ million)
  • Exhibits52: Chart on Diagnostics - Year-over-year growth 2023-2028 (%)
  • Exhibits53: Data Table on Diagnostics - Year-over-year growth 2023-2028 (%)
  • Exhibits54: Chart on Therapeutics - Market size and forecast 2023-2028 ($ million)
  • Exhibits55: Data Table on Therapeutics - Market size and forecast 2023-2028 ($ million)
  • Exhibits56: Chart on Therapeutics - Year-over-year growth 2023-2028 (%)
  • Exhibits57: Data Table on Therapeutics - Year-over-year growth 2023-2028 (%)
  • Exhibits58: Market opportunity by End-user ($ million)
  • Exhibits59: Data Table on Market opportunity by End-user ($ million)
  • Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits61: Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits62: Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits63: Chart on Geographic comparison
  • Exhibits64: Data Table on Geographic comparison
  • Exhibits65: Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibits66: Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibits67: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits68: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits69: Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibits70: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibits71: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits72: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits73: Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibits74: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibits75: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits76: Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits77: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibits78: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibits79: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits80: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits81: Chart on US - Market size and forecast 2023-2028 ($ million)
  • Exhibits82: Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Exhibits83: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibits84: Data Table on US - Year-over-year growth 2023-2028 (%)
  • Exhibits85: Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibits86: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibits87: Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits88: Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits89: Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibits90: Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibits91: Chart on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits92: Data Table on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits93: Chart on Canada - Market size and forecast 2023-2028 ($ million)
  • Exhibits94: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
  • Exhibits95: Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibits96: Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibits97: Chart on China - Market size and forecast 2023-2028 ($ million)
  • Exhibits98: Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Exhibits99: Chart on China - Year-over-year growth 2023-2028 (%)
  • Exhibits100: Data Table on China - Year-over-year growth 2023-2028 (%)
  • Exhibits101: Market opportunity By Geographical Landscape ($ million)
  • Exhibits102: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits103: Impact of drivers and challenges in 2023 and 2028
  • Exhibits104: Overview on criticality of inputs and factors of differentiation
  • Exhibits105: Overview on factors of disruption
  • Exhibits106: Impact of key risks on business
  • Exhibits107: Companies covered
  • Exhibits108: Matrix on companies position and classification
  • Exhibits109: Bayer AG - Overview
  • Exhibits110: Bayer AG - Business segments
  • Exhibits111: Bayer AG - Key news
  • Exhibits112: Bayer AG - Key offerings
  • Exhibits113: Bayer AG - Segment focus
  • Exhibits114: Bracco Spa - Overview
  • Exhibits115: Bracco Spa - Product / Service
  • Exhibits116: Bracco Spa - Key offerings
  • Exhibits117: Cardinal Health Inc. - Overview
  • Exhibits118: Cardinal Health Inc. - Business segments
  • Exhibits119: Cardinal Health Inc. - Key news
  • Exhibits120: Cardinal Health Inc. - Key offerings
  • Exhibits121: Cardinal Health Inc. - Segment focus
  • Exhibits122: Curium Pharma - Overview
  • Exhibits123: Curium Pharma - Product / Service
  • Exhibits124: Curium Pharma - Key offerings
  • Exhibits125: Eckert and Ziegler AG - Overview
  • Exhibits126: Eckert and Ziegler AG - Business segments
  • Exhibits127: Eckert and Ziegler AG - Key news
  • Exhibits128: Eckert and Ziegler AG - Key offerings
  • Exhibits129: Eckert and Ziegler AG - Segment focus
  • Exhibits130: General Electric Co. - Overview
  • Exhibits131: General Electric Co. - Business segments
  • Exhibits132: General Electric Co. - Key news
  • Exhibits133: General Electric Co. - Key offerings
  • Exhibits134: General Electric Co. - Segment focus
  • Exhibits135: IBA Radiopharma Solutions - Overview
  • Exhibits136: IBA Radiopharma Solutions - Business segments
  • Exhibits137: IBA Radiopharma Solutions - Key news
  • Exhibits138: IBA Radiopharma Solutions - Key offerings
  • Exhibits139: IBA Radiopharma Solutions - Segment focus
  • Exhibits140: Jubilant Pharmova Ltd. - Overview
  • Exhibits141: Jubilant Pharmova Ltd. - Business segments
  • Exhibits142: Jubilant Pharmova Ltd. - Key offerings
  • Exhibits143: Jubilant Pharmova Ltd. - Segment focus
  • Exhibits144: Lantheus Holdings Inc. - Overview
  • Exhibits145: Lantheus Holdings Inc. - Business segments
  • Exhibits146: Lantheus Holdings Inc. - Key offerings
  • Exhibits147: Lantheus Holdings Inc. - Segment focus
  • Exhibits148: NorthStar Medical Radioisotopes LLC - Overview
  • Exhibits149: NorthStar Medical Radioisotopes LLC - Product / Service
  • Exhibits150: NorthStar Medical Radioisotopes LLC - Key offerings
  • Exhibits151: Novartis AG - Overview
  • Exhibits152: Novartis AG - Business segments
  • Exhibits153: Novartis AG - Key news
  • Exhibits154: Novartis AG - Key offerings
  • Exhibits155: Novartis AG - Segment focus
  • Exhibits156: NTP Radioisotopes SOC Ltd. - Overview
  • Exhibits157: NTP Radioisotopes SOC Ltd. - Product / Service
  • Exhibits158: NTP Radioisotopes SOC Ltd. - Key offerings
  • Exhibits159: PharmaLogic Holdings Corp. - Overview
  • Exhibits160: PharmaLogic Holdings Corp. - Product / Service
  • Exhibits161: PharmaLogic Holdings Corp. - Key offerings
  • Exhibits162: Siemens AG - Overview
  • Exhibits163: Siemens AG - Business segments
  • Exhibits164: Siemens AG - Key news
  • Exhibits165: Siemens AG - Key offerings
  • Exhibits166: Siemens AG - Segment focus
  • Exhibits167: Sotera Health Co. - Overview
  • Exhibits168: Sotera Health Co. - Business segments
  • Exhibits169: Sotera Health Co. - Key offerings
  • Exhibits170: Sotera Health Co. - Segment focus
  • Exhibits171: Inclusions checklist
  • Exhibits172: Exclusions checklist
  • Exhibits173: Currency conversion rates for US$
  • Exhibits174: Research methodology
  • Exhibits175: Information sources
  • Exhibits176: Data validation
  • Exhibits177: Validation techniques employed for market sizing
  • Exhibits178: Data synthesis
  • Exhibits179: 360 degree market analysis
  • Exhibits180: List of abbreviations
目次
Product Code: IRTNTR43963

The radiopharmaceuticals market is forecasted to grow by USD 6280.6 mn during 2023-2028, accelerating at a CAGR of 12.17% during the forecast period. The report on the radiopharmaceuticals market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising incidence of neurological disorders, growing cancer cases rising investment in the oncology market, and minimal side effects of radiopharmaceuticals.

Technavio's radiopharmaceuticals market is segmented as below:

Market Scope
Base Year2024
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 202410.62%
CAGR12.17%
Incremental Value$6280.6mn

BySource

  • Cyclotrons
  • Nuclear reactors

ByEnd-user

  • Diagnostics
  • Therapeutics

ByGeography

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the production of cyclotron-based radiopharmaceuticals as one of the prime reasons driving the radiopharmaceuticals market growth during the next few years. Also, the discovery and development of new radiopharmaceuticals and improvement in healthcare infrastructure in emerging economies will lead to sizable demand in the market.

The report on the radiopharmaceuticals market covers the following areas:

  • Radiopharmaceuticals market sizing
  • Radiopharmaceuticals market forecast
  • Radiopharmaceuticals market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading radiopharmaceuticals market vendors that include Bayer AG, Bracco Spa, Cardinal Health Inc., Curium Pharma, Eckert and Ziegler AG, General Electric Co., IBA Radiopharma Solutions, Jubilant Pharmova Ltd., Lantheus Holdings Inc., Mallinckrodt Plc, NorthStar Medical Radioisotopes LLC, Novartis AG, NTP Radioisotopes SOC Ltd., PharmaLogic Holdings Corp., Positron Corp., Radiomedix Inc., Siemens AG, Sinotau Pharmaceuticals, Sotera Health Co., and Telix Pharmaceuticals Ltd. Also, the radiopharmaceuticals market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by Source
    • Executive Summary - Chart on Market Segmentation by End-user
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 2.2 Market characteristics
    • Market characteristics analysis
  • 2.3 Value chain analysis
    • Value Chain Analysis

3 Market Sizing

  • 3.1 Market definition
    • Offerings of companies included in the market definition
  • 3.2 Market segment analysis
    • Market segments
  • 3.3 Market size 2023
  • 3.4 Market outlook: Forecast for 2023-2028
    • Chart on Global - Market size and forecast 2023-2028 ($ million)
    • Data Table on Global - Market size and forecast 2023-2028 ($ million)
    • Chart on Global Market: Year-over-year growth 2023-2028 (%)
    • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

  • 4.1 Global Radiopharmaceuticals Market 2018 - 2022
    • Historic Market Size - Data Table on Global Radiopharmaceuticals Market 2018 - 2022 ($ million)
  • 4.2 Source segment analysis 2018 - 2022
    • Historic Market Size - Source Segment 2018 - 2022 ($ million)
  • 4.3 End-user segment analysis 2018 - 2022
    • Historic Market Size - End-user Segment 2018 - 2022 ($ million)
  • 4.4 Geography segment analysis 2018 - 2022
    • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • 4.5 Country segment analysis 2018 - 2022
    • Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
    • Five forces analysis - Comparison between 2023 and 2028
  • 5.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2023 and 2028
  • 5.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • 5.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2023 and 2028
  • 5.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2023 and 2028
  • 5.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2023 and 2028
  • 5.7 Market condition
    • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Source

  • 6.1 Market segments
    • Chart on Source - Market share 2023-2028 (%)
    • Data Table on Source - Market share 2023-2028 (%)
  • 6.2 Comparison by Source
    • Chart on Comparison by Source
    • Data Table on Comparison by Source
  • 6.3 Cyclotrons - Market size and forecast 2023-2028
    • Chart on Cyclotrons - Market size and forecast 2023-2028 ($ million)
    • Data Table on Cyclotrons - Market size and forecast 2023-2028 ($ million)
    • Chart on Cyclotrons - Year-over-year growth 2023-2028 (%)
    • Data Table on Cyclotrons - Year-over-year growth 2023-2028 (%)
  • 6.4 Nuclear reactors - Market size and forecast 2023-2028
    • Chart on Nuclear reactors - Market size and forecast 2023-2028 ($ million)
    • Data Table on Nuclear reactors - Market size and forecast 2023-2028 ($ million)
    • Chart on Nuclear reactors - Year-over-year growth 2023-2028 (%)
    • Data Table on Nuclear reactors - Year-over-year growth 2023-2028 (%)
  • 6.5 Market opportunity by Source
    • Market opportunity by Source ($ million)
    • Data Table on Market opportunity by Source ($ million)

7 Market Segmentation by End-user

  • 7.1 Market segments
    • Chart on End-user - Market share 2023-2028 (%)
    • Data Table on End-user - Market share 2023-2028 (%)
  • 7.2 Comparison by End-user
    • Chart on Comparison by End-user
    • Data Table on Comparison by End-user
  • 7.3 Diagnostics - Market size and forecast 2023-2028
    • Chart on Diagnostics - Market size and forecast 2023-2028 ($ million)
    • Data Table on Diagnostics - Market size and forecast 2023-2028 ($ million)
    • Chart on Diagnostics - Year-over-year growth 2023-2028 (%)
    • Data Table on Diagnostics - Year-over-year growth 2023-2028 (%)
  • 7.4 Therapeutics - Market size and forecast 2023-2028
    • Chart on Therapeutics - Market size and forecast 2023-2028 ($ million)
    • Data Table on Therapeutics - Market size and forecast 2023-2028 ($ million)
    • Chart on Therapeutics - Year-over-year growth 2023-2028 (%)
    • Data Table on Therapeutics - Year-over-year growth 2023-2028 (%)
  • 7.5 Market opportunity by End-user
    • Market opportunity by End-user ($ million)
    • Data Table on Market opportunity by End-user ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2023-2028 (%)
    • Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • 9.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2023-2028
    • Chart on North America - Market size and forecast 2023-2028 ($ million)
    • Data Table on North America - Market size and forecast 2023-2028 ($ million)
    • Chart on North America - Year-over-year growth 2023-2028 (%)
    • Data Table on North America - Year-over-year growth 2023-2028 (%)
  • 9.4 Europe - Market size and forecast 2023-2028
    • Chart on Europe - Market size and forecast 2023-2028 ($ million)
    • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
    • Chart on Europe - Year-over-year growth 2023-2028 (%)
    • Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • 9.5 Asia - Market size and forecast 2023-2028
    • Chart on Asia - Market size and forecast 2023-2028 ($ million)
    • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
    • Chart on Asia - Year-over-year growth 2023-2028 (%)
    • Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
    • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
    • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
    • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • 9.7 US - Market size and forecast 2023-2028
    • Chart on US - Market size and forecast 2023-2028 ($ million)
    • Data Table on US - Market size and forecast 2023-2028 ($ million)
    • Chart on US - Year-over-year growth 2023-2028 (%)
    • Data Table on US - Year-over-year growth 2023-2028 (%)
  • 9.8 Germany - Market size and forecast 2023-2028
    • Chart on Germany - Market size and forecast 2023-2028 ($ million)
    • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
    • Chart on Germany - Year-over-year growth 2023-2028 (%)
    • Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • 9.9 UK - Market size and forecast 2023-2028
    • Chart on UK - Market size and forecast 2023-2028 ($ million)
    • Data Table on UK - Market size and forecast 2023-2028 ($ million)
    • Chart on UK - Year-over-year growth 2023-2028 (%)
    • Data Table on UK - Year-over-year growth 2023-2028 (%)
  • 9.10 Canada - Market size and forecast 2023-2028
    • Chart on Canada - Market size and forecast 2023-2028 ($ million)
    • Data Table on Canada - Market size and forecast 2023-2028 ($ million)
    • Chart on Canada - Year-over-year growth 2023-2028 (%)
    • Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • 9.11 China - Market size and forecast 2023-2028
    • Chart on China - Market size and forecast 2023-2028 ($ million)
    • Data Table on China - Market size and forecast 2023-2028 ($ million)
    • Chart on China - Year-over-year growth 2023-2028 (%)
    • Data Table on China - Year-over-year growth 2023-2028 (%)
  • 9.12 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ million)
    • Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2023 and 2028
  • 10.4 Market opportunities/restraints

11 Competitive Landscape

  • 11.1 Overview
  • 11.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 11.3 Landscape disruption
    • Overview on factors of disruption
  • 11.4 Industry risks
    • Impact of key risks on business

12 Competitive Analysis

  • 12.1 Companies profiled
    • Companies covered
  • 12.2 Market positioning of companies
    • Matrix on companies position and classification
  • 12.3 Bayer AG
    • Bayer AG - Overview
    • Bayer AG - Business segments
    • Bayer AG - Key news
    • Bayer AG - Key offerings
    • Bayer AG - Segment focus
  • 12.4 Bracco Spa
    • Bracco Spa - Overview
    • Bracco Spa - Product / Service
    • Bracco Spa - Key offerings
  • 12.5 Cardinal Health Inc.
    • Cardinal Health Inc. - Overview
    • Cardinal Health Inc. - Business segments
    • Cardinal Health Inc. - Key news
    • Cardinal Health Inc. - Key offerings
    • Cardinal Health Inc. - Segment focus
  • 12.6 Curium Pharma
    • Curium Pharma - Overview
    • Curium Pharma - Product / Service
    • Curium Pharma - Key offerings
  • 12.7 Eckert and Ziegler AG
    • Eckert and Ziegler AG - Overview
    • Eckert and Ziegler AG - Business segments
    • Eckert and Ziegler AG - Key news
    • Eckert and Ziegler AG - Key offerings
    • Eckert and Ziegler AG - Segment focus
  • 12.8 General Electric Co.
    • General Electric Co. - Overview
    • General Electric Co. - Business segments
    • General Electric Co. - Key news
    • General Electric Co. - Key offerings
    • General Electric Co. - Segment focus
  • 12.9 IBA Radiopharma Solutions
    • IBA Radiopharma Solutions - Overview
    • IBA Radiopharma Solutions - Business segments
    • IBA Radiopharma Solutions - Key news
    • IBA Radiopharma Solutions - Key offerings
    • IBA Radiopharma Solutions - Segment focus
  • 12.10 Jubilant Pharmova Ltd.
    • Jubilant Pharmova Ltd. - Overview
    • Jubilant Pharmova Ltd. - Business segments
    • Jubilant Pharmova Ltd. - Key offerings
    • Jubilant Pharmova Ltd. - Segment focus
  • 12.11 Lantheus Holdings Inc.
    • Lantheus Holdings Inc. - Overview
    • Lantheus Holdings Inc. - Business segments
    • Lantheus Holdings Inc. - Key offerings
    • Lantheus Holdings Inc. - Segment focus
  • 12.12 NorthStar Medical Radioisotopes LLC
    • NorthStar Medical Radioisotopes LLC - Overview
    • NorthStar Medical Radioisotopes LLC - Product / Service
    • NorthStar Medical Radioisotopes LLC - Key offerings
  • 12.13 Novartis AG
    • Novartis AG - Overview
    • Novartis AG - Business segments
    • Novartis AG - Key news
    • Novartis AG - Key offerings
    • Novartis AG - Segment focus
  • 12.14 NTP Radioisotopes SOC Ltd.
    • NTP Radioisotopes SOC Ltd. - Overview
    • NTP Radioisotopes SOC Ltd. - Product / Service
    • NTP Radioisotopes SOC Ltd. - Key offerings
  • 12.15 PharmaLogic Holdings Corp.
    • PharmaLogic Holdings Corp. - Overview
    • PharmaLogic Holdings Corp. - Product / Service
    • PharmaLogic Holdings Corp. - Key offerings
  • 12.16 Siemens AG
    • Siemens AG - Overview
    • Siemens AG - Business segments
    • Siemens AG - Key news
    • Siemens AG - Key offerings
    • Siemens AG - Segment focus
  • 12.17 Sotera Health Co.
    • Sotera Health Co. - Overview
    • Sotera Health Co. - Business segments
    • Sotera Health Co. - Key offerings
    • Sotera Health Co. - Segment focus

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 13.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 13.4 Research methodology
    • Research methodology
  • 13.5 Data procurement
    • Information sources
  • 13.6 Data validation
    • Data validation
  • 13.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 13.8 Data synthesis
    • Data synthesis
  • 13.9 360 degree market analysis
    • 360 degree market analysis
  • 13.10 List of abbreviations
    • List of abbreviations